Composition (public abstract)
- Scaffold: erythritol-capped linear penta-histidine peptide
- MW: ≈ 868 Da (C₃₆H₄₉N₁₅O₁₁; as reported in v7)
- pKa: ≈ 6.0–6.1 (five imidazole side chains)
- Design principle: inverse of classic histidine-release systems—Channel E on when protonated at endosomal pH
- Validation: DFT (B3LYP-D3/def2-TZVP), multi-replica MD / MM-PBSA, and a 34-node NetworkX model as published
